| http://dbpedia.org/ontology/abstract
|
APP-FUBINACA is an indazole-based syntheti … APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested. It contains a phenylalanine amino acid residue in its structure.anine amino acid residue in its structure.
|
| http://dbpedia.org/ontology/casNumber
|
1185282-03-4
|
| http://dbpedia.org/ontology/fdaUniiCode
|
TW71LSK9DG
|
| http://dbpedia.org/ontology/pubchem
|
58124515
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/APP-FUBINACA.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
47249688
|
| http://dbpedia.org/ontology/wikiPageLength
|
3630
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1082421624
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/APINACA +
, http://dbpedia.org/resource/Synthetic_cannabinoid +
, http://dbpedia.org/resource/Category:Cannabinoids +
, http://dbpedia.org/resource/Designer_drug +
, http://dbpedia.org/resource/APP-BINACA +
, http://dbpedia.org/resource/MDMB-FUBINACA +
, http://dbpedia.org/resource/BMS-F +
, http://dbpedia.org/resource/Phenylalanine +
, http://dbpedia.org/resource/PX-1 +
, http://dbpedia.org/resource/ADBICA +
, http://dbpedia.org/resource/ADB-CHMINACA +
, http://dbpedia.org/resource/ADB-PINACA +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:Indazolecarboxamides +
, http://dbpedia.org/resource/PX-3 +
, http://dbpedia.org/resource/AB-PINACA +
, http://dbpedia.org/resource/AB-CHFUPYCA +
, http://dbpedia.org/resource/MDMB-CHMICA +
, http://dbpedia.org/resource/AB-FUBINACA +
, http://dbpedia.org/resource/CB1_receptor +
, http://dbpedia.org/resource/Indazole +
, http://dbpedia.org/resource/PX-2 +
, http://dbpedia.org/resource/ADB-FUBINACA +
, http://dbpedia.org/resource/5F-ADB +
, http://dbpedia.org/resource/5F-AB-PINACA +
, http://dbpedia.org/resource/5F-AMB +
, http://dbpedia.org/resource/AB-CHMINACA +
, http://dbpedia.org/resource/5F-APINACA +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/APICA_%28synthetic_cannabinoid_drug%29 +
|
| http://dbpedia.org/property/c
|
24
|
| http://dbpedia.org/property/casNumber
|
1185282
|
| http://dbpedia.org/property/f
|
1
|
| http://dbpedia.org/property/h
|
21
|
| http://dbpedia.org/property/iupacName
|
N--1-[methyl]-1H-indazole-3-carboxamide
|
| http://dbpedia.org/property/legalCa
|
Schedule II
|
| http://dbpedia.org/property/legalDe
|
NpSG
|
| http://dbpedia.org/property/legalUk
|
Class B
|
| http://dbpedia.org/property/n
|
4
|
| http://dbpedia.org/property/o
|
2
|
| http://dbpedia.org/property/pubchem
|
58124515
|
| http://dbpedia.org/property/smiles
|
O=CC2=NNC4=C2C=CC=C4
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
TZXBEYFALIFOAG-FQEVSTJZSA-N
|
| http://dbpedia.org/property/unii
|
TW71LSK9DG
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Div_col +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Div_col_end +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Cannabinoid-stub +
, http://dbpedia.org/resource/Template:Cannabinoids +
, http://dbpedia.org/resource/Template:Cannabinoidergics +
, http://dbpedia.org/resource/Template:Short_description +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:Cannabinoids +
, http://dbpedia.org/resource/Category:Indazolecarboxamides +
, http://dbpedia.org/resource/Category:Fluoroarenes +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Cannabinoid +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/APP-FUBINACA?oldid=1082421624&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/APP-FUBINACA.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/APP-FUBINACA +
|
| owl:sameAs |
http://dbpedia.org/resource/APP-FUBINACA +
, https://global.dbpedia.org/id/yAQC +
, http://www.wikidata.org/entity/Q20707637 +
, http://yago-knowledge.org/resource/APP-FUBINACA +
|
| rdf:type |
http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/ChemicalSubstance +
|
| rdfs:comment |
APP-FUBINACA is an indazole-based syntheti … APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested. It contains a phenylalanine amino acid residue in its structure.anine amino acid residue in its structure.
|
| rdfs:label |
APP-FUBINACA
|
